President Bill Clinton to Deliver Plenary Remarks at AdvaMed 2009
Washington, D.C. – AdvaMed 2009 is pleased to announce that President Bill Clinton, founder of the William J. Clinton Foundation and the 42nd President of the United States, will speak at AdvaMed 2009: The MedTech Conference on Wednesday, October 14 at the Walter E. Washington Convention Center in Washington, D.C. His speech, entitled “Embracing our Common Humanity,” will be open to all full-conference registrants.
President Clinton served the United States for eight years during a time of unprecedented prosperity and change. Now, President Clinton is a powerful voice for progress around the world as he shares his unique insights and observations with audiences around the world. President Clinton’s public speeches describe the challenge of globalization, emphasize our growing interdependence, and point the way toward a common future based on shared goals and values.
President Clinton’s remarks will be a feature of the three-day conference bringing together industry, investor, media and policy-maker stakeholders within the medical technology community. President Clinton’s address and question and answer session will be delivered during the Wednesday plenary breakfast. Other distinguished plenary speakers at the October 12-14, AdvaMed 2009 conference include: Sir Bruce Keogh, Medical Director, National Health Service, England; M. Philippe Sauvage Deputy Chief of Staff, French Minister of Health; Dr. Joshua M. Sharfstein Principal Deputy Commissioner, U.S. Food the Drug Administration (FDA).
For more information on the AdvaMed 2009 conference program and speakers visit www.advamed2009.com.
Testimonials
"AdvaMed is an exceptional conference for us. Every day I'm worried about how do I grow my business, how do I reach out to the community and AdvaMed really provides a forum for both emerging growth and more substantial companies to come together and interact and meet in a way that is effective and efficient and gives me a real opportunity to continue to sell my business to my target audience."
David Lucchino Semprus Biosciences